Originally Posted by
David B
It's the same article, sparky! lol. Read pg18, 3rd paragraph. Look it's not the end of the world. This just provides insight into the types of issues that company's that work in the medical space have to work with when taking their products to market. They already have some clinical data that suggests that cxbladder has a role to play in the clinical management of bladder cancer. All they need to do is to build on that, along with the other companies that work in this space, and eventually make their case backed up by their data for the guidelines to be updated to include the use of biomarkers in bladder cancer.
Believe you me, everybody knows about the potential for the use of biomarkers in cancer diagnosis and the monitoring of treatment outcomes. A lot of work has been put into it, and it promises once established and widely adopted, to make major advances.